Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05165927 · ClinicalTrials.gov registry record · NA

Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation

A NA study of Hip Injuries, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05165927 is a NA study of Hip Injuries that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 2,104-participant average among 7 other Hip Injuries trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05165927, a NA study of Hip Injuries, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partner with SAGA to use the BFR cuffs as the intervention method. The BFR cuff will be added to the current SOC for hip scope PT for the intervention group.

Conditions Studied

Interventions

  • DEVICE BFR

Study Locations (1)

Colorado

  • UCHealth Steadman Hawkins Clinic Denver - Englewood

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-04-29
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT05165927

The ClinicalTrials.gov registry entry for NCT05165927 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,104-participant average among 7 other Hip Injuries trials with a reported enrollment target (94% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Injuries appearing as the primary indexed condition, and to 1 intervention - of which BFR is the first listed.

NCT05165927 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05165927 about?

NCT05165927 is a clinical study titled "Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation". The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partn...

What is the current status of trial NCT05165927?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-04-29. Estimated completion is 2025-12-31.

What conditions does trial NCT05165927 study?

This clinical trial studies the following conditions: Hip Injuries.

What interventions are being tested in trial NCT05165927?

The interventions under investigation include: BFR (DEVICE).

Who is sponsoring clinical trial NCT05165927?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05165927 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.